Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Tissue-specific expression of IgG receptors by human macrophages ex vivo.

Bruggeman CW, Houtzager J, Dierdorp B, Kers J, Pals ST, Lutter R, van Gulik T, den Haan JMM, van den Berg TK, van Bruggen R, Kuijpers TW.

PLoS One. 2019 Oct 15;14(10):e0223264. doi: 10.1371/journal.pone.0223264. eCollection 2019.

2.

Bacterial inclusion bodies function as vehicles for dendritic cell-mediated T cell responses.

Schetters STT, Jong WSP, Kruijssen LJW, Saparoea HBVDBV, Engels S, Unger WWJ, Houben D, den Haan JMM, Luirink J, Kooyk YV.

Cell Mol Immunol. 2019 Oct 8. doi: 10.1038/s41423-019-0298-x. [Epub ahead of print] No abstract available.

PMID:
31595053
3.

Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8+ T cells.

Schetters STT, Jong WSP, Horrevorts SK, Kruijssen LJW, Engels S, Stolk D, Daleke-Schermerhorn MH, Garcia-Vallejo J, Houben D, Unger WWJ, den Haan JMM, Luirink J, van Kooyk Y.

Acta Biomater. 2019 Jun;91:248-257. doi: 10.1016/j.actbio.2019.04.033. Epub 2019 Apr 17.

4.

Activation of CD8⁺ T Cell Responses after Melanoma Antigen Targeting to CD169⁺ Antigen Presenting Cells in Mice and Humans.

van Dinther D, Lopez Venegas M, Veninga H, Olesek K, Hoogterp L, Revet M, Ambrosini M, Kalay H, Stöckl J, van Kooyk Y, den Haan JMM.

Cancers (Basel). 2019 Feb 5;11(2). pii: E183. doi: 10.3390/cancers11020183.

5.

CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors.

Bar-Ephraim YE, Koning JJ, Burniol Ruiz E, Konijn T, Mourits VP, Lakeman KA, Boon L, Bögels M, van Maanen JP, Den Haan JMM, van Egmond M, Bouma G, Reijmers RM, Mebius RE.

J Immunol. 2019 Jan 1;202(1):171-182. doi: 10.4049/jimmunol.1701153. Epub 2018 Nov 30.

PMID:
30504420
6.

CD169+ Macrophages Capture and Dendritic Cells Instruct: The Interplay of the Gatekeeper and the General of the Immune System.

Grabowska J, Lopez-Venegas MA, Affandi AJ, den Haan JMM.

Front Immunol. 2018 Oct 26;9:2472. doi: 10.3389/fimmu.2018.02472. eCollection 2018. Review.

7.

Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.

van Dinther D, Veninga H, Revet M, Hoogterp L, Olesek K, Grabowska J, Borg EGF, Kalay H, van Kooyk Y, den Haan JMM.

Front Immunol. 2018 Sep 6;9:1997. doi: 10.3389/fimmu.2018.01997. eCollection 2018.

8.

Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity.

Schetters STT, Kruijssen LJW, Crommentuijn MHW, Kalay H, Ochando J, den Haan JMM, Garcia-Vallejo JJ, van Kooyk Y.

Front Immunol. 2018 May 7;9:990. doi: 10.3389/fimmu.2018.00990. eCollection 2018.

9.

Red pulp macrophages in the human spleen are a distinct cell population with a unique expression of Fc-γ receptors.

Nagelkerke SQ, Bruggeman CW, den Haan JMM, Mul EPJ, van den Berg TK, van Bruggen R, Kuijpers TW.

Blood Adv. 2018 Apr 24;2(8):941-953. doi: 10.1182/bloodadvances.2017015008.

10.

Dendritic Cell Migration to Skin-Draining Lymph Nodes Is Controlled by Dermatan Sulfate and Determines Adaptive Immunity Magnitude.

Nadafi R, Koning JJ, Veninga H, Stachtea XN, Konijn T, Zwiers A, Malmström A, den Haan JMM, Mebius RE, Maccarana M, Reijmers RM.

Front Immunol. 2018 Feb 8;9:206. doi: 10.3389/fimmu.2018.00206. eCollection 2018.

11.

Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-Priming.

van Dinther D, Veninga H, Iborra S, Borg EGF, Hoogterp L, Olesek K, Beijer MR, Schetters STT, Kalay H, Garcia-Vallejo JJ, Franken KL, Cham LB, Lang KS, van Kooyk Y, Sancho D, Crocker PR, den Haan JMM.

Cell Rep. 2018 Feb 6;22(6):1484-1495. doi: 10.1016/j.celrep.2018.01.021.

12.

Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A mice.

Lai JD, Cartier D, Hartholt RB, Swystun LL, van Velzen AS, den Haan JMM, Hough C, Voorberg J, Lillicrap D.

J Thromb Haemost. 2018 Mar;16(3):533-545. doi: 10.1111/jth.13936. Epub 2018 Feb 2.

PMID:
29285874
13.

Receptor Activator of NF-κB Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal Zone.

Habbeddine M, Verthuy C, Rastoin O, Chasson L, Bebien M, Bajenoff M, Adriouch S, den Haan JMM, Penninger JM, Lawrence T.

Cell Rep. 2017 Nov 28;21(9):2515-2527. doi: 10.1016/j.celrep.2017.10.111.

14.

Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation.

Bar-Ephraim YE, Cornelissen F, Papazian N, Konijn T, Hoogenboezem RM, Sanders MA, Westerman BA, Gönültas M, Kwekkeboom J, Den Haan JMM, Reijmers RM, Mebius RE, Cupedo T.

Cell Rep. 2017 Oct 17;21(3):823-833. doi: 10.1016/j.celrep.2017.09.070.

15.

Schistosome egg antigens, including the glycoprotein IPSE/alpha-1, trigger the development of regulatory B cells.

Haeberlein S, Obieglo K, Ozir-Fazalalikhan A, Chayé MAM, Veninga H, van der Vlugt LEPM, Voskamp A, Boon L, den Haan JMM, Westerhof LB, Wilbers RHP, Schots A, Schramm G, Hokke CH, Smits HH.

PLoS Pathog. 2017 Jul 28;13(7):e1006539. doi: 10.1371/journal.ppat.1006539. eCollection 2017 Jul.

16.

Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines.

van Dinther D, Stolk DA, van de Ven R, van Kooyk Y, de Gruijl TD, den Haan JMM.

J Leukoc Biol. 2017 Oct;102(4):1017-1034. doi: 10.1189/jlb.5MR0217-059RR. Epub 2017 Jul 20. Review.

17.

Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.

Perdicchio M, Ilarregui JM, Verstege MI, Cornelissen LA, Schetters ST, Engels S, Ambrosini M, Kalay H, Veninga H, den Haan JM, van Berkel LA, Samsom JN, Crocker PR, Sparwasser T, Berod L, Garcia-Vallejo JJ, van Kooyk Y, Unger WW.

Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3329-34. doi: 10.1073/pnas.1507706113. Epub 2016 Mar 3.

18.

Intestinal epithelial cell transported TLR2 ligand stimulates Ly6C⁺ monocyte differentiation in a G-CSF dependent manner.

Hiemstra IH, Vrijland K, Hogenboom MM, Bouma G, Kraal G, den Haan JM.

Immunobiology. 2015 Nov;220(11):1255-65. doi: 10.1016/j.imbio.2015.06.015. Epub 2015 Jun 26.

PMID:
26143228
19.

Cholinergic receptor activation on epithelia protects against cytokine-induced barrier dysfunction.

Dhawan S, Hiemstra IH, Verseijden C, Hilbers FW, Te Velde AA, Willemsen LE, Stap J, den Haan JM, de Jonge WJ.

Acta Physiol (Oxf). 2015 Apr;213(4):846-59. doi: 10.1111/apha.12469. Erratum in: Acta Physiol (Oxf). 2017 Aug;220(4):501.

PMID:
25683465
20.

Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses.

Veninga H, Borg EG, Vreeman K, Taylor PR, Kalay H, van Kooyk Y, Kraal G, Martinez-Pomares L, den Haan JM.

Eur J Immunol. 2015 Mar;45(3):747-57. doi: 10.1002/eji.201444983. Epub 2015 Jan 14. Erratum in: Eur J Immunol. 2016 Feb;46(2):493.

21.

The activation of the adaptive immune system: cross-talk between antigen-presenting cells, T cells and B cells.

den Haan JM, Arens R, van Zelm MC.

Immunol Lett. 2014 Dec;162(2 Pt B):103-12. doi: 10.1016/j.imlet.2014.10.011. Epub 2014 Oct 16. Review.

PMID:
25455596
22.

Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation.

Baptista AP, Roozendaal R, Reijmers RM, Koning JJ, Unger WW, Greuter M, Keuning ED, Molenaar R, Goverse G, Sneeboer MM, den Haan JM, Boes M, Mebius RE.

Elife. 2014 Nov 19;3. doi: 10.7554/eLife.04433.

23.

Vitamin A metabolism and mucosal immune function are distinct between BALB/c and C57BL/6 mice.

Goverse G, Olivier BJ, Molenaar R, Knippenberg M, Greuter M, Konijn T, Cook EC, Beijer MR, Fedor DM, den Haan JM, Napoli JL, Bouma G, Mebius RE.

Eur J Immunol. 2015 Jan;45(1):89-100. doi: 10.1002/eji.201343340. Epub 2014 Nov 17.

24.

The identification and developmental requirements of colonic CD169⁺ macrophages.

Hiemstra IH, Beijer MR, Veninga H, Vrijland K, Borg EG, Olivier BJ, Mebius RE, Kraal G, den Haan JM.

Immunology. 2014 Jun;142(2):269-78. doi: 10.1111/imm.12251.

25.

Vitamin A and dendritic cell differentiation.

Beijer MR, Kraal G, den Haan JM.

Immunology. 2014 May;142(1):39-45. doi: 10.1111/imm.12228. Review.

26.

Excreted/secreted Trichuris suis products reduce barrier function and suppress inflammatory cytokine production of intestinal epithelial cells.

Hiemstra IH, Klaver EJ, Vrijland K, Kringel H, Andreasen A, Bouma G, Kraal G, van Die I, den Haan JM.

Mol Immunol. 2014 Jul;60(1):1-7. doi: 10.1016/j.molimm.2014.03.003. Epub 2014 Apr 2.

PMID:
24705296
27.

Macrophage heterogeneity in lymphoid tissues.

den Haan JM, Martinez-Pomares L.

Semin Immunopathol. 2013 Sep;35(5):541-52. doi: 10.1007/s00281-013-0378-4. Epub 2013 Apr 12.

PMID:
23579230
28.

A crucial role for retinoic acid in the development of Notch-dependent murine splenic CD8- CD4- and CD4+ dendritic cells.

Beijer MR, Molenaar R, Goverse G, Mebius RE, Kraal G, den Haan JM.

Eur J Immunol. 2013 Jun;43(6):1608-16. doi: 10.1002/eji.201343325. Epub 2013 Apr 27.

29.

Stromal cells of the mouse spleen.

den Haan JM, Mebius RE, Kraal G.

Front Immunol. 2012 Jul 12;3:201. doi: 10.3389/fimmu.2012.00201. eCollection 2012.

30.

Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.

Hiemstra IH, Bouma G, Geerts D, Kraal G, den Haan JM.

Mol Immunol. 2012 Oct;52(3-4):264-72. doi: 10.1016/j.molimm.2012.06.007. Epub 2012 Jun 27.

PMID:
22750073
31.

Innate immune functions of macrophage subpopulations in the spleen.

den Haan JM, Kraal G.

J Innate Immun. 2012;4(5-6):437-45. doi: 10.1159/000335216. Epub 2012 Feb 7. Review.

32.

Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.

Schwandt T, Schumak B, Gielen GH, Jüngerkes F, Schmidbauer P, Klocke K, Staratschek-Jox A, van Rooijen N, Kraal G, Ludwig-Portugall I, Franken L, Wehner S, Kalff JC, Weber O, Kirschning C, Coch C, Kalinke U, Wenzel J, Kurts C, Zawatzky R, Holzmann B, Layland L, Schultze JL, Burgdorf S, den Haan JM, Knolle PA, Limmer A.

EMBO J. 2012 Jan 4;31(1):201-13. doi: 10.1038/emboj.2011.380. Epub 2011 Oct 28.

33.

Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells.

Backer R, Schwandt T, Greuter M, Oosting M, Jüngerkes F, Tüting T, Boon L, O'Toole T, Kraal G, Limmer A, den Haan JM.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):216-21. doi: 10.1073/pnas.0909541107. Epub 2009 Dec 14.

34.

P-glycoprotein acts as an immunomodulator during neuroinflammation.

Kooij G, Backer R, Koning JJ, Reijerkerk A, van Horssen J, van der Pol SM, Drexhage J, Schinkel A, Dijkstra CD, den Haan JM, Geijtenbeek TB, de Vries HE.

PLoS One. 2009 Dec 8;4(12):e8212. doi: 10.1371/journal.pone.0008212.

35.

Different mechanisms regulate CD4(+) T cell independent induction of oral and nasal tolerance of CD8(+) T cells.

van den Berg H, Greuter M, Kraal G, den Haan JM.

Immunobiology. 2010;215(2):163-71. doi: 10.1016/j.imbio.2009.01.012. Epub 2009 Mar 10.

PMID:
19278748
36.

CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens.

Backer R, van Leeuwen F, Kraal G, den Haan JM.

Eur J Immunol. 2008 Feb;38(2):370-80. doi: 10.1002/eji.200737647.

37.
39.

General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses.

den Haan JM, Mutis T, Blokland E, IJzerman AP, Goulmy E.

Blood. 2002 Feb 1;99(3):985-92.

PMID:
11807003
40.

Antigen presentation to CD8+ T cells: cross-priming in infectious diseases.

den Haan JM, Bevan MJ.

Curr Opin Immunol. 2001 Aug;13(4):437-41. Review.

PMID:
11498299
41.

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

den Haan JM, Lehar SM, Bevan MJ.

J Exp Med. 2000 Dec 18;192(12):1685-96.

42.

A novel helper role for CD4 T cells.

den Haan JM, Bevan MJ.

Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):12950-2. Review. No abstract available.

43.

Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique.

Pierce RA, Field ED, den Haan JM, Caldwell JA, White FM, Marto JA, Wang W, Frost LM, Blokland E, Reinhardus C, Shabanowitz J, Hunt DF, Goulmy E, Engelhard VH.

J Immunol. 1999 Dec 15;163(12):6360-4.

44.

Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR.

Wilke M, Pool J, den Haan JM, Goulmy E.

Tissue Antigens. 1998 Oct;52(4):312-7.

PMID:
9820596
45.

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL, Reinhardus C, Shabanowitz J, Offringa R, Hunt DF, Engelhard VH, Goulmy E.

Science. 1998 Feb 13;279(5353):1054-7.

46.

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition.

Meadows L, Wang W, den Haan JM, Blokland E, Reinhardus C, Drijfhout JW, Shabanowitz J, Pierce R, Agulnik AI, Bishop CE, Hunt DF, Goulmy E, Engelhard VH.

Immunity. 1997 Mar;6(3):273-81.

47.

Conservation of minor histocompatibility antigens between human and non-human primates.

den Haan JM, Bontrop RE, Pool J, Sherman N, Blokland E, Engelhard VH, Hunt DF, Goulmy E.

Eur J Immunol. 1996 Nov;26(11):2680-5.

PMID:
8921955
48.

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein.

Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AI, Hendrickson RC, Bishop CE, et al.

Science. 1995 Sep 15;269(5230):1588-90.

PMID:
7667640
49.

Identification of a graft versus host disease-associated human minor histocompatibility antigen.

den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, et al.

Science. 1995 Jun 9;268(5216):1476-80.

PMID:
7539551
50.

In vivo detection of fluorescent tumor-specific cytotoxic T cell clones.

Toes RE, den Haan JM, Feltkamp MC, Blom RJ, Melief CJ, Claassen E, Kast WM.

J Immunol Methods. 1993 Jul 6;163(1):23-32.

PMID:
8393053

Supplemental Content

Loading ...
Support Center